Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres.
about
LI-cadherin: a marker of gastric metaplasia and neoplasiaCDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancerManagement of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade PortuA novel method for detecting single glandular intestinal metaplasia in the mucosal surface of the fixed stomach using methylene blue.Correlation between epithelial cell proliferation and histological grading in gastric mucosa.Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma.Screening for and surveillance of gastric cancer.Review article: pre-neoplastic states of the gastric mucosa--a practical approach for the perplexed clinician.Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study.Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed upCDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancerDynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to ChinaClonal analysis of isolated intestinal metaplastic glands of stomach using X linked polymorphismGastric pathology in patients with common variable immunodeficiencyComplete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis.Patterns of gastritis in patients with gastro-oesophageal reflux diseaseGastric intestinal metaplasia: subtypes and natural history.Inflammation and intestinal metaplasia at the squamocolumnar junction in young patients with or without Helicobacter pylori infection.Metaplastic change in mesenchymal stem cells induced by activated ras oncogeneThe Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes.Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori -associated gastric diseases.Assessing risks for gastric cancer: new tools for pathologists.Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.Mucin histochemistry of stomach in metaplasia and adenocarcinoma: An observation.Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.Method to quantitate intestinal metaplasia of stomach by image analysis.The morphology of gastritis.Role of p53 in the progression of gastric cancerGastric atrophy, diagnosing and staging.Detection of sulfated glycoproteins in intestinal metaplasia: a comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewis(a) carbohydrate epitope.Subtypes of intestinal metaplasia and Helicobacter pylori.Is intestinal metaplasia a risk for gastric carcinoma?Patterns of gastric atrophy in intestinal type gastric carcinoma.Epstein-Barr virus infection in non-carcinomatous gastric epithelium.Site-dependent development of complete and incomplete intestinal metaplasia types in the human stomach.Non-Helicobacter pylori Gastric Intestinal Metaplasia in Children: A Series of Cases and Review of the Literature.Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade PortugAscorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study
P2860
Q24669690-2474E2F3-60A4-47E3-9C9A-C513FEED82C9Q28251382-042A9030-B411-4C60-9B8D-DFB7B316053BQ30426539-05BFD006-3DAD-4ADA-ADEA-A9387FDFCE19Q30993975-1DE9B774-85C7-4A3A-B294-08AAC292058EQ33608819-7EC89DB2-B211-4E06-B832-D634AF96E341Q33838334-AA56B31A-0B34-4A4C-B9E4-D119A2CEAF51Q34326563-079B286B-E5C9-4846-9755-9B33831A760EQ34327976-261CADB4-1610-45A4-901A-03392DB75200Q34393172-52EAD5C6-FB5D-4FE8-BFA8-BB5E12F91882Q34395562-DB8D3CA2-4E2F-4421-B3DE-0D5DD12C20CEQ34853497-76CF2202-75AD-4469-9D0C-0FFDA7993698Q35010597-A89B9BF4-F0EF-46AA-8DF2-FA2C2CF27F4CQ35151103-B65DF99C-AC6D-4B6B-889E-3CFE8D4A8012Q35350933-DA9547E0-DA06-4D3B-A21D-D125CAC4CA0DQ35356135-F2B494DC-6D53-4C53-A6B1-A7A22E7AAFAEQ35357755-122D3175-CCA9-4113-9967-74B03C6C26D2Q35357928-26A87F9A-AC6F-40FD-B4C2-EE8CE2CD199BQ35399651-B7BF03CF-F640-4341-87BC-CACDFA5D1E19Q35598364-657F6F3D-3724-4061-B553-32C5C5966B8BQ35811937-C6AAE4E6-7504-4880-9DDD-F019F0EB7897Q36305324-9DEAC8DA-4C58-470F-BE66-DA5D7343BA87Q36308356-6564D2BB-D9BF-4B39-9198-A4CFCE791211Q36606183-B08F1826-771F-4978-8E5B-799248F5E6AFQ37067317-1EB077A2-325E-44AE-98A8-5E45767799DFQ37599224-8D9BF25A-307D-4848-ABEF-1A56086D3187Q37809363-96EDDE45-AF12-4D02-AD04-C20D95E0CD2DQ41273210-9B211A72-1444-4642-BCE9-3A9B93C5E2DFQ41354871-A5C7D271-7FF6-4953-8FBA-A6941D400EDBQ41773412-3E3839BA-857A-40F8-9ED3-EF6142AAA4CDQ42737657-6EC8A6C2-1AD5-4351-9CE4-65B53B1F92EEQ43010977-66B28CC8-55B5-4967-A0A2-899FA74D3557Q43221232-6F7F57CC-5133-4C31-A281-E138034E8D47Q43249371-23C33516-14C7-4049-9272-9BFB977CA91DQ43937939-5AE9EB1D-3850-434D-910E-5EF4611FC1ACQ45758646-7F5125CD-DCEF-424B-AFE1-9581863BF5A9Q50796049-843BFBAC-93CD-43AD-956F-35727FD5CC0AQ55273072-4AF2A8E8-C882-4910-8184-4FF97C3B11ECQ57698678-58C9E493-6C7E-45F1-BA0E-8057750A4EF2Q57821645-C9BD683D-5FB2-4172-94C2-709F1606F645
P2860
Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres.
description
1985 nî lūn-bûn
@nan
1985 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Incomplete sulphomucin-secreti ...... tive study from three centres.
@ast
Incomplete sulphomucin-secreti ...... tive study from three centres.
@en
Incomplete sulphomucin-secreti ...... tive study from three centres.
@nl
type
label
Incomplete sulphomucin-secreti ...... tive study from three centres.
@ast
Incomplete sulphomucin-secreti ...... tive study from three centres.
@en
Incomplete sulphomucin-secreti ...... tive study from three centres.
@nl
prefLabel
Incomplete sulphomucin-secreti ...... tive study from three centres.
@ast
Incomplete sulphomucin-secreti ...... tive study from three centres.
@en
Incomplete sulphomucin-secreti ...... tive study from three centres.
@nl
P2093
P2860
P356
P1433
P1476
Incomplete sulphomucin-secreti ...... tive study from three centres.
@en
P2093
Bogomoletz WV
Chauveinc P
Goldfain D
P2860
P304
P356
10.1136/GUT.26.12.1319
P407
P577
1985-12-01T00:00:00Z